Gene symbol: Traf6

Organism: Rattus norvegicus

Summary: Predicted to enable several functions, including enzyme binding activity; tumor necrosis factor receptor binding activity; and ubiquitin protein ligase activity. Involved in JNK cascade; interleukin-1-mediated signaling pathway; and positive regulation of smooth muscle cell proliferation. Part of protein-containing complex. Orthologous to human TRAF6 (TNF receptor associated factor 6). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 311245 Ensembl:ENSRNOG00000004639 AllianceGenome:RGD:1306853


GO Annotation


Category Term ID Term description
Process GO:0000122 Negative regulation of transcription by RNA polymerase II
Process GO:0000165 MAPK cascade
Process GO:0000209 Protein polyubiquitination
Process GO:0001503 Ossification
Process GO:0001701 In utero embryonic development
Process GO:0001773 Myeloid dendritic cell activation
Process GO:0001775 Cell activation
Process GO:0001817 Regulation of cytokine production
Process GO:0001819 Positive regulation of cytokine production
Process GO:0001838 Embryonic epithelial tube formation
Process GO:0001841 Neural tube formation
Process GO:0001843 Neural tube closure
Process GO:0001894 Tissue homeostasis
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0002009 Morphogenesis of an epithelium
Process GO:0002237 Response to molecule of bacterial origin
Process GO:0002250 Adaptive immune response
Process GO:0002253 Activation of immune response
Process GO:0002274 Myeloid leukocyte activation
Process GO:0002376 Immune system process
Process GO:0002429 Immune response-activating cell surface receptor signaling pathway
Process GO:0002460 Adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
Process GO:0002478 Antigen processing and presentation of exogenous peptide antigen
Process GO:0002495 Antigen processing and presentation of peptide antigen via MHC class II
Process GO:0002504 Antigen processing and presentation of peptide or polysaccharide antigen via MHC class II
Process GO:0002520 Immune system development
Process GO:0002521 Leukocyte differentiation
Process GO:0002573 Myeloid leukocyte differentiation
Process GO:0002637 Regulation of immunoglobulin production
Process GO:0002682 Regulation of immune system process
Process GO:0002684 Positive regulation of immune system process
Process GO:0002694 Regulation of leukocyte activation
Process GO:0002696 Positive regulation of leukocyte activation
Process GO:0002697 Regulation of immune effector process
Process GO:0002699 Positive regulation of immune effector process
Process GO:0002700 Regulation of production of molecular mediator of immune response
Process GO:0002702 Positive regulation of production of molecular mediator of immune response
Process GO:0002703 Regulation of leukocyte mediated immunity
Process GO:0002705 Positive regulation of leukocyte mediated immunity
Process GO:0002706 Regulation of lymphocyte mediated immunity
Process GO:0002708 Positive regulation of lymphocyte mediated immunity
Process GO:0002709 Regulation of T cell mediated immunity
Process GO:0002711 Positive regulation of T cell mediated immunity
Process GO:0002718 Regulation of cytokine production involved in immune response
Process GO:0002720 Positive regulation of cytokine production involved in immune response
Process GO:0002724 Regulation of T cell cytokine production
Process GO:0002726 Positive regulation of T cell cytokine production
Process GO:0002757 Immune response-activating signal transduction
Process GO:0002761 Regulation of myeloid leukocyte differentiation
Process GO:0002763 Positive regulation of myeloid leukocyte differentiation
Process GO:0002764 Immune response-regulating signaling pathway
Process GO:0002768 Immune response-regulating cell surface receptor signaling pathway
Process GO:0002819 Regulation of adaptive immune response
Process GO:0002821 Positive regulation of adaptive immune response
Process GO:0002822 Regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
Process GO:0002824 Positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
Process GO:0002831 Regulation of response to biotic stimulus
Process GO:0002833 Positive regulation of response to biotic stimulus
Process GO:0002931 Response to ischemia
Process GO:0006355 Regulation of transcription, DNA-templated
Process GO:0006357 Regulation of transcription by RNA polymerase II
Process GO:0006807 Nitrogen compound metabolic process
Process GO:0006950 Response to stress
Process GO:0006955 Immune response
Process GO:0006974 Cellular response to DNA damage stimulus
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007249 I-kappaB kinase/NF-kappaB signaling
Process GO:0007250 Activation of NF-kappaB-inducing kinase activity
Process GO:0007254 JNK cascade
Process GO:0007275 Multicellular organism development
Process GO:0007399 Nervous system development
Process GO:0008152 Metabolic process
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0009605 Response to external stimulus
Process GO:0009607 Response to biotic stimulus
Process GO:0009617 Response to bacterium
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009790 Embryo development
Process GO:0009792 Embryo development ending in birth or egg hatching
Process GO:0009887 Animal organ morphogenesis
Process GO:0009888 Tissue development
Process GO:0009889 Regulation of biosynthetic process
Process GO:0009890 Negative regulation of biosynthetic process
Process GO:0009891 Positive regulation of biosynthetic process
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010468 Regulation of gene expression
Process GO:0010556 Regulation of macromolecule biosynthetic process
Process GO:0010557 Positive regulation of macromolecule biosynthetic process
Process GO:0010558 Negative regulation of macromolecule biosynthetic process
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010628 Positive regulation of gene expression
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010941 Regulation of cell death
Process GO:0014020 Primary neural tube formation
Process GO:0016331 Morphogenesis of embryonic epithelium
Process GO:0016567 Protein ubiquitination
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019221 Cytokine-mediated signaling pathway
Process GO:0019222 Regulation of metabolic process
Process GO:0019538 Protein metabolic process
Process GO:0019882 Antigen processing and presentation
Process GO:0019884 Antigen processing and presentation of exogenous antigen
Process GO:0019886 Antigen processing and presentation of exogenous peptide antigen via MHC class II
Process GO:0021915 Neural tube development
Process GO:0022407 Regulation of cell-cell adhesion
Process GO:0022409 Positive regulation of cell-cell adhesion
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0030097 Hemopoiesis
Process GO:0030099 Myeloid cell differentiation
Process GO:0030154 Cell differentiation
Process GO:0030155 Regulation of cell adhesion
Process GO:0030316 Osteoclast differentiation
Process GO:0031098 Stress-activated protein kinase signaling cascade
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031324 Negative regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031326 Regulation of cellular biosynthetic process
Process GO:0031327 Negative regulation of cellular biosynthetic process
Process GO:0031328 Positive regulation of cellular biosynthetic process
Process GO:0031399 Regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0031664 Regulation of lipopolysaccharide-mediated signaling pathway
Process GO:0031666 Positive regulation of lipopolysaccharide-mediated signaling pathway
Process GO:0032101 Regulation of response to external stimulus
Process GO:0032103 Positive regulation of response to external stimulus
Process GO:0032147 Activation of protein kinase activity
Process GO:0032446 Protein modification by small protein conjugation
Process GO:0032496 Response to lipopolysaccharide
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032655 Regulation of interleukin-12 production
Process GO:0032663 Regulation of interleukin-2 production
Process GO:0032675 Regulation of interleukin-6 production
Process GO:0032735 Positive regulation of interleukin-12 production
Process GO:0032743 Positive regulation of interleukin-2 production
Process GO:0032755 Positive regulation of interleukin-6 production
Process GO:0032872 Regulation of stress-activated MAPK cascade
Process GO:0032874 Positive regulation of stress-activated MAPK cascade
Process GO:0032944 Regulation of mononuclear cell proliferation
Process GO:0032946 Positive regulation of mononuclear cell proliferation
Process GO:0033209 Tumor necrosis factor-mediated signaling pathway
Process GO:0033554 Cellular response to stress
Process GO:0033674 Positive regulation of kinase activity
Process GO:0033993 Response to lipid
Process GO:0034097 Response to cytokine
Process GO:0034612 Response to tumor necrosis factor
Process GO:0035148 Tube formation
Process GO:0035239 Tube morphogenesis
Process GO:0035295 Tube development
Process GO:0035556 Intracellular signal transduction
Process GO:0036211 Protein modification process
Process GO:0038061 NIK/NF-kappaB signaling
Process GO:0042088 T-helper 1 type immune response
Process GO:0042102 Positive regulation of T cell proliferation
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042129 Regulation of T cell proliferation
Process GO:0042221 Response to chemical
Process GO:0042325 Regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042475 Odontogenesis of dentin-containing tooth
Process GO:0042476 Odontogenesis
Process GO:0042592 Homeostatic process
Process GO:0042981 Regulation of apoptotic process
Process GO:0043009 Chordate embryonic development
Process GO:0043011 Myeloid dendritic cell differentiation
Process GO:0043067 Regulation of programmed cell death
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043122 Regulation of I-kappaB kinase/NF-kappaB signaling
Process GO:0043123 Positive regulation of I-kappaB kinase/NF-kappaB signaling
Process GO:0043170 Macromolecule metabolic process
Process GO:0043207 Response to external biotic stimulus
Process GO:0043388 Positive regulation of DNA binding
Process GO:0043405 Regulation of MAP kinase activity
Process GO:0043406 Positive regulation of MAP kinase activity
Process GO:0043408 Regulation of MAPK cascade
Process GO:0043410 Positive regulation of MAPK cascade
Process GO:0043412 Macromolecule modification
Process GO:0043506 Regulation of JUN kinase activity
Process GO:0043507 Positive regulation of JUN kinase activity
Process GO:0043549 Regulation of kinase activity
Process GO:0044093 Positive regulation of molecular function
Process GO:0044238 Primary metabolic process
Process GO:0044419 Biological process involved in interspecies interaction between organisms
Process GO:0045321 Leukocyte activation
Process GO:0045453 Bone resorption
Process GO:0045595 Regulation of cell differentiation
Process GO:0045597 Positive regulation of cell differentiation
Process GO:0045637 Regulation of myeloid cell differentiation
Process GO:0045639 Positive regulation of myeloid cell differentiation
Process GO:0045670 Regulation of osteoclast differentiation
Process GO:0045672 Positive regulation of osteoclast differentiation
Process GO:0045785 Positive regulation of cell adhesion
Process GO:0045859 Regulation of protein kinase activity
Process GO:0045860 Positive regulation of protein kinase activity
Process GO:0045892 Negative regulation of transcription, DNA-templated
Process GO:0045893 Positive regulation of transcription, DNA-templated
Process GO:0045934 Negative regulation of nucleobase-containing compound metabolic process
Process GO:0045935 Positive regulation of nucleobase-containing compound metabolic process
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0045944 Positive regulation of transcription by RNA polymerase II
Process GO:0046328 Regulation of JNK cascade
Process GO:0046330 Positive regulation of JNK cascade
Process GO:0046849 Bone remodeling
Process GO:0048002 Antigen processing and presentation of peptide antigen
Process GO:0048468 Cell development
Process GO:0048513 Animal organ development
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048534 Hematopoietic or lymphoid organ development
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048598 Embryonic morphogenesis
Process GO:0048646 Anatomical structure formation involved in morphogenesis
Process GO:0048660 Regulation of smooth muscle cell proliferation
Process GO:0048661 Positive regulation of smooth muscle cell proliferation
Process GO:0048729 Tissue morphogenesis
Process GO:0048731 System development
Process GO:0048771 Tissue remodeling
Process GO:0048856 Anatomical structure development
Process GO:0048869 Cellular developmental process
Process GO:0048871 Multicellular organismal homeostasis
Process GO:0050670 Regulation of lymphocyte proliferation
Process GO:0050671 Positive regulation of lymphocyte proliferation
Process GO:0050776 Regulation of immune response
Process GO:0050778 Positive regulation of immune response
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050851 Antigen receptor-mediated signaling pathway
Process GO:0050852 T cell receptor signaling pathway
Process GO:0050863 Regulation of T cell activation
Process GO:0050865 Regulation of cell activation
Process GO:0050867 Positive regulation of cell activation
Process GO:0050870 Positive regulation of T cell activation
Process GO:0050896 Response to stimulus
Process GO:0051090 Regulation of DNA-binding transcription factor activity
Process GO:0051091 Positive regulation of DNA-binding transcription factor activity
Process GO:0051092 Positive regulation of NF-kappaB transcription factor activity
Process GO:0051094 Positive regulation of developmental process
Process GO:0051098 Regulation of binding
Process GO:0051099 Positive regulation of binding
Process GO:0051101 Regulation of DNA binding
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051172 Negative regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051240 Positive regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051249 Regulation of lymphocyte activation
Process GO:0051251 Positive regulation of lymphocyte activation
Process GO:0051252 Regulation of RNA metabolic process
Process GO:0051253 Negative regulation of RNA metabolic process
Process GO:0051254 Positive regulation of RNA metabolic process
Process GO:0051338 Regulation of transferase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051403 Stress-activated MAPK cascade
Process GO:0051707 Response to other organism
Process GO:0051716 Cellular response to stimulus
Process GO:0051865 Protein autoubiquitination
Process GO:0060249 Anatomical structure homeostasis
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060429 Epithelium development
Process GO:0060562 Epithelial tube morphogenesis
Process GO:0060606 Tube closure
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070302 Regulation of stress-activated protein kinase signaling cascade
Process GO:0070304 Positive regulation of stress-activated protein kinase signaling cascade
Process GO:0070498 interleukin-1-mediated signaling pathway
Process GO:0070534 Protein K63-linked ubiquitination
Process GO:0070555 Response to interleukin-1
Process GO:0070647 Protein modification by small protein conjugation or removal
Process GO:0070663 Regulation of leukocyte proliferation
Process GO:0070665 Positive regulation of leukocyte proliferation
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071216 Cellular response to biotic stimulus
Process GO:0071219 Cellular response to molecule of bacterial origin
Process GO:0071222 Cellular response to lipopolysaccharide
Process GO:0071310 Cellular response to organic substance
Process GO:0071345 Cellular response to cytokine stimulus
Process GO:0071347 Cellular response to interleukin-1
Process GO:0071356 Cellular response to tumor necrosis factor
Process GO:0071396 Cellular response to lipid
Process GO:0071704 Organic substance metabolic process
Process GO:0071900 Regulation of protein serine/threonine kinase activity
Process GO:0071902 Positive regulation of protein serine/threonine kinase activity
Process GO:0072175 Epithelial tube formation
Process GO:0080090 Regulation of primary metabolic process
Process GO:0080134 Regulation of response to stress
Process GO:0080135 Regulation of cellular response to stress
Process GO:0097028 Dendritic cell differentiation
Process GO:0097396 Response to interleukin-17
Process GO:0097398 Cellular response to interleukin-17
Process GO:0097400 interleukin-17-mediated signaling pathway
Process GO:1901222 Regulation of NIK/NF-kappaB signaling
Process GO:1901224 Positive regulation of NIK/NF-kappaB signaling
Process GO:1901564 Organonitrogen compound metabolic process
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1902105 Regulation of leukocyte differentiation
Process GO:1902107 Positive regulation of leukocyte differentiation
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1902679 Negative regulation of RNA biosynthetic process
Process GO:1902680 Positive regulation of RNA biosynthetic process
Process GO:1903037 Regulation of leukocyte cell-cell adhesion
Process GO:1903039 Positive regulation of leukocyte cell-cell adhesion
Process GO:1903131 Mononuclear cell differentiation
Process GO:1903506 Regulation of nucleic acid-templated transcription
Process GO:1903507 Negative regulation of nucleic acid-templated transcription
Process GO:1903508 Positive regulation of nucleic acid-templated transcription
Process GO:1903706 Regulation of hemopoiesis
Process GO:1903708 Positive regulation of hemopoiesis
Process GO:1904994 Regulation of leukocyte adhesion to vascular endothelial cell
Process GO:1904996 Positive regulation of leukocyte adhesion to vascular endothelial cell
Process GO:2000026 Regulation of multicellular organismal development
Process GO:2000677 Regulation of transcription regulatory region DNA binding
Process GO:2000679 Positive regulation of transcription regulatory region DNA binding
Process GO:2001141 Regulation of RNA biosynthetic process
Component GO:0005622 Intracellular anatomical structure
Component GO:0005634 Nucleus
Component GO:0005737 Cytoplasm
Component GO:0005811 Lipid droplet
Component GO:0005829 Cytosol
Component GO:0005886 Plasma membrane
Component GO:0005887 Integral component of plasma membrane
Component GO:0005938 Cell cortex
Component GO:0009898 Cytoplasmic side of plasma membrane
Component GO:0016020 Membrane
Component GO:0016021 Integral component of membrane
Component GO:0031224 Intrinsic component of membrane
Component GO:0031226 Intrinsic component of plasma membrane
Component GO:0032991 Protein-containing complex
Component GO:0035631 CD40 receptor complex
Component GO:0043226 Organelle
Component GO:0043227 Membrane-bounded organelle
Component GO:0043228 Non-membrane-bounded organelle
Component GO:0043229 Intracellular organelle
Component GO:0043231 Intracellular membrane-bounded organelle
Component GO:0043232 Intracellular non-membrane-bounded organelle
Component GO:0043235 Receptor complex
Component GO:0048471 Perinuclear region of cytoplasm
Component GO:0071944 Cell periphery
Component GO:0098552 Side of membrane
Component GO:0098562 Cytoplasmic side of membrane
Component GO:0098796 Membrane protein complex
Component GO:0098797 Plasma membrane protein complex
Component GO:0098802 Plasma membrane signaling receptor complex
Component GO:0110165 Cellular anatomical entity
Function GO:0003824 Catalytic activity
Function GO:0004842 Ubiquitin-protein transferase activity
Function GO:0005102 Signaling receptor binding
Function GO:0005126 Cytokine receptor binding
Function GO:0005164 Tumor necrosis factor receptor binding
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0008270 Zinc ion binding
Function GO:0016740 Transferase activity
Function GO:0019787 Ubiquitin-like protein transferase activity
Function GO:0019899 Enzyme binding
Function GO:0019900 Kinase binding
Function GO:0019901 Protein kinase binding
Function GO:0031435 Mitogen-activated protein kinase kinase kinase binding
Function GO:0031624 Ubiquitin conjugating enzyme binding
Function GO:0031625 Ubiquitin protein ligase binding
Function GO:0031996 Thioesterase binding
Function GO:0032813 Tumor necrosis factor receptor superfamily binding
Function GO:0042802 Identical protein binding
Function GO:0042826 Histone deacetylase binding
Function GO:0043167 Ion binding
Function GO:0043169 Cation binding
Function GO:0043422 Protein kinase B binding
Function GO:0044389 Ubiquitin-like protein ligase binding
Function GO:0044390 Ubiquitin-like protein conjugating enzyme binding
Function GO:0046872 Metal ion binding
Function GO:0046914 Transition metal ion binding
Function GO:0047485 Protein N-terminus binding
Function GO:0061630 Ubiquitin protein ligase activity
Function GO:0061659 Ubiquitin-like protein ligase activity
Function GO:0140096 Catalytic activity, acting on a protein

Pathway annotation


Category Term ID Term description
RCTM RNO-1257604 PIP3 activates AKT signaling
RCTM RNO-1280215 Cytokine Signaling in Immune system
RCTM RNO-1280218 Adaptive Immune System
RCTM RNO-162582 Signal Transduction
RCTM RNO-166016 Toll Like Receptor 4 (TLR4) Cascade
RCTM RNO-166058 MyD88:MAL(TIRAP) cascade initiated on plasma membrane
RCTM RNO-166166 MyD88-independent TLR4 cascade
RCTM RNO-168138 Toll Like Receptor 9 (TLR9) Cascade
RCTM RNO-168142 Toll Like Receptor 10 (TLR10) Cascade
RCTM RNO-168164 Toll Like Receptor 3 (TLR3) Cascade
RCTM RNO-168176 Toll Like Receptor 5 (TLR5) Cascade
RCTM RNO-168179 Toll Like Receptor TLR1:TLR2 Cascade
RCTM RNO-168181 Toll Like Receptor 7/8 (TLR7/8) Cascade
RCTM RNO-168188 Toll Like Receptor TLR6:TLR2 Cascade
RCTM RNO-168249 Innate Immune System
RCTM RNO-168256 Immune System
RCTM RNO-168638 NOD1/2 Signaling Pathway
RCTM RNO-168643 Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
RCTM RNO-168898 Toll-like Receptor Cascades
RCTM RNO-181438 Toll Like Receptor 2 (TLR2) Cascade
RCTM RNO-193639 p75NTR signals via NF-kB
RCTM RNO-193704 p75 NTR receptor-mediated signalling
RCTM RNO-199418 Negative regulation of the PI3K/AKT network
RCTM RNO-202403 TCR signaling
RCTM RNO-202424 Downstream TCR signaling
RCTM RNO-204998 Cell death signalling via NRAGE, NRIF and NADE
RCTM RNO-205043 NRIF signals cell death from the nucleus
RCTM RNO-209543 p75NTR recruits signalling complexes
RCTM RNO-209560 NF-kB is activated and signals survival
RCTM RNO-2454202 Fc epsilon receptor (FCERI) signaling
RCTM RNO-2871837 FCERI mediated NF-kB activation
RCTM RNO-392499 Metabolism of proteins
RCTM RNO-445989 TAK1-dependent IKK and NF-kappa-B activation
RCTM RNO-446652 Interleukin-1 family signaling
RCTM RNO-448424 Interleukin-17 signaling
RCTM RNO-449147 Signaling by Interleukins
RCTM RNO-450294 MAP kinase activation
RCTM RNO-450302 Activated TAK1 mediates p38 MAPK activation
RCTM RNO-450321 JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
RCTM RNO-5607764 CLEC7A (Dectin-1) signaling
RCTM RNO-5621481 C-type lectin receptors (CLRs)
RCTM RNO-5688426 Deubiquitination
RCTM RNO-5689880 Ub-specific processing proteases
RCTM RNO-5689896 Ovarian tumor domain proteases
RCTM RNO-597592 Post-translational protein modification
RCTM RNO-6811558 PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
RCTM RNO-73887 Death Receptor Signaling
RCTM RNO-9006925 Intracellular signaling by second messengers
RCTM RNO-9020702 Interleukin-1 signaling
RCTM RNO-937039 IRAK1 recruits IKK complex
RCTM RNO-937042 IRAK2 mediated activation of TAK1 complex
RCTM RNO-937061 TRIF(TICAM1)-mediated TLR4 signaling
RCTM RNO-937072 TRAF6-mediated induction of TAK1 complex within TLR4 complex
RCTM RNO-9645460 Alpha-protein kinase 1 signaling pathway
RCTM RNO-975138 TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
RCTM RNO-975144 IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
RCTM RNO-975155 MyD88 dependent cascade initiated on endosome
RCTM RNO-975163 IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
RCTM RNO-9758274 Regulation of NF-kappa B signaling
RCTM RNO-975871 MyD88 cascade initiated on plasma membrane
WikiPathways WP1278 EBV LMP1 signaling
WikiPathways WP1309 Toll-like receptor signaling pathway
WikiPathways WP355 IL-1 signaling pathway
WikiPathways WP358 MAPK signaling pathway
WikiPathways WP457 TNF-alpha NF-kB signaling pathway
KEGG rno04010 MAPK signaling pathway
KEGG rno04064 NF-kappa B signaling pathway
KEGG rno04120 Ubiquitin mediated proteolysis
KEGG rno04140 Autophagy - animal
KEGG rno04144 Endocytosis
KEGG rno04380 Osteoclast differentiation
KEGG rno04620 Toll-like receptor signaling pathway
KEGG rno04621 NOD-like receptor signaling pathway
KEGG rno04622 RIG-I-like receptor signaling pathway
KEGG rno04657 IL-17 signaling pathway
KEGG rno04722 Neurotrophin signaling pathway
KEGG rno04936 Alcoholic liver disease
KEGG rno05132 Salmonella infection
KEGG rno05133 Pertussis
KEGG rno05135 Yersinia infection
KEGG rno05140 Leishmaniasis
KEGG rno05142 Chagas disease
KEGG rno05145 Toxoplasmosis
KEGG rno05152 Tuberculosis
KEGG rno05160 Hepatitis C
KEGG rno05161 Hepatitis B
KEGG rno05162 Measles
KEGG rno05168 Herpes simplex virus 1 infection
KEGG rno05169 Epstein-Barr virus infection
KEGG rno05170 Human immunodeficiency virus 1 infection
KEGG rno05171 Coronavirus disease - COVID-19
KEGG rno05200 Pathways in cancer
KEGG rno05222 Small cell lung cancer
KEGG rno05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
KEGG rno05417 Lipid and atherosclerosis

Expression profile of Traf6 in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 6.267601
GSM2685202 MX2 tissue: Myocardium gender: female 5.0906177
GSM2685203 MX3 tissue: Myocardium gender: female 6.7291055
GSM2685204 MX4 tissue: Myocardium gender: male 5.296011
GSM2685205 DZ1 tissue: Myocardium gender: male 6.6191807
GSM2685206 DZ2 tissue: Myocardium gender: male 5.7084374
GSM2685207 DZ3 tissue: Myocardium gender: female 6.548454
GSM2685208 DZ4 tissue: Myocardium gender: female 6.435155
GSM2685209 JJ1 tissue: Myocardium gender: male 6.4424305
GSM2685210 JJ2 tissue: Myocardium gender: female 6.0831184
GSM2685211 JJ3 tissue: Myocardium gender: female 5.4438386
GSM2685212 JJ4 tissue: Myocardium gender: male 6.290948
GSM2685213 NG1 tissue: Myocardium gender: male 5.8610597
GSM2685214 NG2 tissue: Myocardium gender: female 5.9376626
GSM2685215 NG3 tissue: Myocardium gender: male 5.5495358
GSM2685216 NG4 tissue: Myocardium gender: female 5.641803
GSM2685217 YL1 tissue: Myocardium gender: male 5.494903
GSM2685218 YL2 tissue: Myocardium gender: male 6.2241344
GSM2685219 YL3 tissue: Myocardium gender: female 6.546233
GSM2685220 YL4 tissue: Myocardium gender: female 6.2637844
GSM2685221 QC1 tissue: Myocardium gender: male 6.425287
GSM2685222 QC2 tissue: Myocardium gender: male 6.3330393
GSM2685223 QC3 tissue: Myocardium gender: female 6.0815907
GSM2685224 QC4 tissue: Myocardium gender: female 5.5611033

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.160172315
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.311176233
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.272648219
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.267655964
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.108376975
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.223594754

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 200.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 141.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 224.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 162.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 186.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 191.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 211.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 399.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 167.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 175.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 149.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 247.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 108.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 135.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 166.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 175.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 7.872127
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 7.704863
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 7.753943
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 7.586033
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 7.90203
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 7.894429

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 7.221
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 6.381
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 9.056
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 6.045
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 6.428

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 8.09957632825
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 8.084293911749999
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 7.83682655275

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 50.45175
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 48.883824999999995
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 51.352425000000004
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 40.61415
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 42.704074999999996
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 45.997550000000004
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 47.7752
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 44.71625
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 45.1909

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 9.093
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 9.48803
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 10.1638
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 9.75956
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 9.38511
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 9.26541
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 8.92144
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 8.83563
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 8.47342
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 8.58374
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 9.20603
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 9.20117
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 8.54359
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 9.01897
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 8.17838
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 8.43574

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.585413
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.111086
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.120855
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.315997
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 6.426884
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.263108
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.378044
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.335439
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.262974
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 6.27517
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.096553
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.37647
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.282124
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.030692
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 6.405461
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.441159
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.410954
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.392914
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.763728
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 6.556866
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.586898
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.312863
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.2101
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.563955
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 6.278452
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.306791
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.487963
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.497479
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.135021
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 6.315397
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.067746
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.311216
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.954247
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.006115
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 6.482019
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.72527
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.710502
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.549951
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.200627
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 6.775123
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.27489
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.200393
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.49327
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.222668
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 6.234879

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 97.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 102.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 107.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 111.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 100.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 107.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 115.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 122.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 113.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 158.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 105.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 112.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 136.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 144.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 119.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 113.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 119.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 102.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 96.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 107.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 97.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 137.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 152.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 119.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 136.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 107.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 142.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 101.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 145.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 131.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 140.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 151.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 156.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 126.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 132.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 134.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 11.576971
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 12.497579
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 13.217491
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 13.847916

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; 0.0982
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 0.0591
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 -0.0127
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.314
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 -0.00261
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 0.074
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 0.00562
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 0.0103
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 -0.0629
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 -0.0269
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.0417
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 0.105

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 7.64644332275
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 7.6457994435
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 8.813643035
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 8.76276672575
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.53817460025
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.8013635775
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 8.93046369125
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 10.195223176499999
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 9.219003572
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 9.68437774575
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.08451163875
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.3886999275
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 9.4961847995
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 9.17588601725
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 10.9561095575
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 10.2256469465
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 8.84418103275
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 9.58601174325
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 9.6441714425
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 9.47140319325
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.5330664795
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.946689311
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 9.83957137325
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 9.788195535749999

ID GSE53897
Title Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1303240 DRG RVM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.751809
GSM1303241 DRG RVM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.633166
GSM1303242 DRG RVM3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.704425
GSM1303243 DRG RVM7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.61727
GSM1303244 DRG RVOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.769842
GSM1303245 DRG RVOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.857439
GSM1303246 DRG RVOx5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 6.063659
GSM1303247 DRG RVOx7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.723586
GSM1303248 DRG RVS4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.805489
GSM1303249 DRG RVS5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.719722
GSM1303250 DRG RVS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.792012
GSM1303251 DRG RVS7 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.870274
GSM1303252 DRG RSM1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.760746
GSM1303253 DRG RSM2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.799545
GSM1303254 DRG RSM4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.83132
GSM1303255 DRG RSM5 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.447665
GSM1303256 DRG RSOx1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.784507
GSM1303257 DRG RSOx2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.698869
GSM1303258 DRG RSOx3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.698869
GSM1303259 DRG RSOx4 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.742047
GSM1303260 DRG RSS1 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.655664
GSM1303261 DRG RSS2 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.703948
GSM1303262 DRG RSS3 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.735442
GSM1303263 DRG RSS6 strain: sprague-dawley age: 3 months tissue: dorsal root ganglion 5.752905

ID GSE55573
Title Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1339443 Mock skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 120.7596
GSM1339444 EA (electroacupuncture) skeletal muscle strain: Wistar age: 8-10 week-old gender: Male 125.0569

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 2676.95071475
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1044.741153425
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 640.26653255
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 2090.598347
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 1344.2438992749999
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1489.63261715
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1413.83111465
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1044.777831225
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1825.8160445
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 817.82547325
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 683.5018882
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1803.4059008
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1312.255302475
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 2405.05670625

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 7.64644332275
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 7.6457994435
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 8.813643035
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 8.76276672575
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.53817460025
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.8013635775
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 8.93046369125
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 10.195223176499999
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 9.219003572
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 9.68437774575
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.08451163875
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.3886999275
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 9.4961847995
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 9.17588601725
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 10.9561095575
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 10.2256469465
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 8.84418103275
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 9.58601174325
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 9.6441714425
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 9.47140319325
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.5330664795
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.946689311
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 9.83957137325
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 9.788195535749999
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 2676.95071475
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1044.741153425
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 640.26653255
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 2090.598347
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 1344.2438992749999
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1489.63261715
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 1413.83111465
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1044.777831225
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1825.8160445
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 817.82547325
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 683.5018882
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1803.4059008
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1312.255302475
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 2405.05670625

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 34.747274999999995
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 43.527074999999996